Related Experiment Video
Updated: May 29, 2025

06:26
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.1K
Optimising the M72/AS01E tuberculosis vaccine candidate phase 3 trial based on the phase 2b trial results
Katie D Dale1, Justin T Denholm2
1Victorian Tuberculosis Program, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Level 5, 792 Elizabeth St, Melbourne, Victoria 3000, Australia; Department of Infectious Diseases, University of Melbourne, At the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, Victoria 3000, Australia.
Vaccine
|February 1, 2025
Abstract
No abstract available in PubMed .

